日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and Validation of a Prognostic Model to Predict Mortality in Patients With Heart Failure With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction

建立和验证预测急性心肌梗死后射血分数轻度降低的心力衰竭患者死亡率的预后模型

Liu, Zhi Can; Zhang, Ling Ling; Peng, Li; Zeng, Jian Ping; Jiang, Ming Yan

New synthetic approaches for the construction of 2-aminophenoxazinone architectures

构建2-氨基吩恶嗪酮结构的新合成方法

Guo, Ning-Yu; Cheng, Xiao-Yi; Dong, Xiao-Dan; Peng, Chun-E; Zhang, Chun; Han, Ya-Ping; Peng, Li-Zeng

A Difluorinated Derivative of ARC-111 Suppresses Intrahepatic Cholangiocarcinoma Growth via Targeting Topoisomerase I

ARC-111 的二氟衍生物通过靶向拓扑异构酶 I 抑制肝内胆管癌的生长

Bai, Yin-Peng; Zhang, Mi; Liu, Jian-Hua; Chen, Gui-Sha; Yang, Cheng-Jie; Deng, Nan; Chen, Chan-Yuan; Wang, Zhi-Ping; Xu, Chuan-Rui; Zhang, Zhi-Jun; Li, Lei; Peng, Li-Zeng; Liu, Min; Liu, Ying-Qian

Seasonal epidemiological and clinical characteristics of pediatric patients with respiratory syncytial virus infection by age during COVID-19: a cross-sectional study

COVID-19 期间儿童呼吸道合胞病毒感染的季节性流行病学和临床特征(按年龄划分):一项横断面研究

Xie, Le-Yun; Peng, Ying-Gang; Wang, Tao; Yu, Tian; Hu, Xian; Yang, Le; Zhong, Li-Li; Peng, Li; Zeng, Sai-Zhen

Novel 1,2,3-Triazole Erlotinib Derivatives as Potent IDO1 Inhibitors: Design, Drug-Target Interactions Prediction, Synthesis, Biological Evaluation, Molecular Docking and ADME Properties Studies.

新型 1,2,3-三唑厄洛替尼衍生物作为强效 IDO1 抑制剂:设计、药物靶点相互作用预测、合成、生物学评价、分子对接和 ADME 性质研究

Xu Gui-Qing, Gong Xiao-Qing, Zhu Ying-Ying, Yao Xiao-Jun, Peng Li-Zeng, Sun Ge, Yang Jian-Xue, Mao Long-Fei

Leukotriene Synthesis Is Critical for Medulloblastoma Progression

白三烯合成对于髓母细胞瘤进展至关重要

Fang Du, Larra Yuelling, Eric H Lee, Yuan Wang, Shengyou Liao, Yan Cheng, Li Zhang, Chaonan Zheng, Suraj Peri, Kathy Q Cai, Jessica M Y Ng, Tom Curran, Peng Li, Zeng-Jie Yang